Shay Capital’s ESSA Pharma EPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-536,533
Closed -$102K 523
2025
Q3
$102K Buy
536,533
+512,185
+2,104% +$614K 0.01% 381
2025
Q2
$41.4K Sell
24,348
-283
-1% -$477 ﹤0.01% 299
2025
Q1
$38.9K Buy
+24,631
New +$41.7K 0.01% 290

Shay Capital's EPIX Position: Q4 2025 in Review

Shay Capital sold out of ESSA Pharma (EPIX) in Q4 2025, closing a stake of 536,533 shares — an estimated $102K sold.

Shay Capital first reported a position in EPIX in Q1 2025 and held it in 3 quarters. The position peaked at $102K in Q3 2025. 0 funds tracked by Wall St. Rank hold EPIX as of Q4 2025.

  • Shay Capital reported no remaining ESSA Pharma position as of Q4 2025 after selling out during the quarter.
  • Shay Capital sold 536,533 ESSA Pharma shares in Q4 2025, an estimated $102K.
  • Shay Capital first reported a position in ESSA Pharma in Q1 2025 and held it in 3 quarters.
  • Shay Capital's ESSA Pharma position peaked at $102K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2025.

Based on Shay Capital's 13F filing for Q4 2025, filed 17 Feb 2026.